Clincosm LogoSign in Get a demo

prostatic neoplasms

Showing NaN - NaN of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Prostatic Tumors Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788), Placebo, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasms
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Macquarie University, New South Wales, Australia
  • +131 more
Jan 5, 2023

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Mobile, Alabama
  • +214 more
Nov 24, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +2 more
  • Mobile, Alabama
  • +257 more
Nov 22, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Fullerton, California
  • +192 more
Oct 17, 2022

Prostatic Tumors, Prostate Cancer, Recurrence Trial in France, Spain, Switzerland ([18F]CTT1057, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostatic Neoplasms
  • +2 more
  • Marseille Cedex 05, France
  • +8 more
Aug 9, 2022

Prostatic Tumors Trial in Worldwide (Niraparib)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Tucson, Arizona
  • +109 more
Aug 2, 2022

Prostatic Tumors, Prostate Cancer Trial in Worldwide ([18F]CTT1057)

Recruiting
  • Prostatic Neoplasms
  • Prostate Cancer
  • Marseille, France
  • +13 more
Jul 20, 2022

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Scottsdale, Arizona
  • +67 more
Jun 30, 2019

Prostatic Tumors Trial in Worldwide (CFG920)

Terminated
  • Prostatic Neoplasms
  • San Francisco, California
  • +6 more
Aug 1, 2018

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • New Orleans, Louisiana
  • +15 more
Mar 23, 2018

Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, prednisone)

Completed
Has Results
  • Prostate Cancer
  • +3 more
  • Birmingham, Alabama
  • +263 more
Feb 14, 2018

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (BAY88-8223))

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (BAY88-8223)
  • Brugge, Belgium
  • +214 more
Mar 30, 2017

Prostatic Tumors Trial in Worldwide (Placebo, Dasatinib, Docetaxel)

Completed
Has Results
  • Prostatic Neoplasms
  • Placebo
  • +3 more
  • Mobile, Alabama
  • +185 more
Aug 23, 2016

Prostatic Tumors, Tumor Metastasis Trial in Worldwide (Aflibercept, Placebo (for aflibercept), Docetaxel)

Completed
Has Results
  • Prostatic Neoplasms
  • Neoplasm Metastasis
  • Bridgewater, New Jersey
  • +30 more
Jun 21, 2016

Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)

Completed
Has Results
  • Prostatic Neoplasms
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +127 more
Apr 10, 2014

Prostatic Tumors Trial in Worldwide (Docetaxel, Leuprolide, Bicalutamide)

Terminated
Has Results
  • Prostatic Neoplasms
  • Bridgewater, New Jersey
  • +8 more
Aug 30, 2013

Prostatic Tumors Trial in Worldwide (CP-751,871, docetaxel, prednisone)

Completed
Has Results
  • Prostatic Neoplasms
  • Los Angeles, California
  • +17 more
Mar 5, 2013

Prostatic Tumors Trial in Worldwide (Prednisone, sunitinib, Placebo)

Terminated
Has Results
  • Prostatic Neoplasms
  • Decatur, Alabama
  • +204 more
Feb 5, 2013

Hormone-Refractory Prostate Cancer, Prostatic Tumors Trial in Worldwide (YM598)

Terminated
  • Hormone-Refractory Prostate Cancer
  • Prostatic Neoplasms
  • Anchorage, Alaska
  • +52 more
Jun 6, 2012

Tumors, Prostatic Tumors Trial in Worldwide (cabazitaxel (XRP6258) (RPR116258), mitoxantrone, prednisone)

Completed
Has Results
  • Neoplasms
  • Prostatic Neoplasms
  • cabazitaxel (XRP6258) (RPR116258)
  • +2 more
  • Bridgewater, New Jersey
  • +25 more
Mar 4, 2011

Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Terminated
  • Prostatic Neoplasms
    • Bridgewater, New Jersey
    • +4 more
    Feb 11, 2011

    Prostatic Tumors Trial in Barcelona (Docetaxel + Estramustine + Hydrocortisone, Docetaxel + Prednisone)

    Terminated
    • Prostatic Neoplasms
    • Docetaxel + Estramustine + Hydrocortisone
    • Docetaxel + Prednisone
    • Barcelona, Spain
      Sanofi-Aventis Administrative Office
    Nov 29, 2010

    Prostatic Tumors Trial in Worldwide (Atrasentan)

    Completed
    • Prostatic Neoplasms
    • Homewood,, Alabama
    • +233 more
    Aug 13, 2007